Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 4036 AL 4050

Alzheimer's Disease Classification Based on Multi-feature Fusion

Madusanka N, Choi HK, So JH, Choi BK.

Curr Med Imaging Rev. 2019;15(2):161-169. doi: 10.2174/1573405614666181012102626.

Possibilities of Dementia Prevention - It is Never Too Early to Start

Morovic S, Budincevic H, Govori V, Demarin V.

J Med Life. 2019 Oct-Dec;12(4):332-337. doi: 10.25122/jml-2019-0088.

Using mouse models to understand Alzheimer's disease mechanisms in the context of trisomy of chromosome 21

Cannavo C, Tosh J, Fisher EMC, Wiseman FK.

Prog Brain Res. 2020;251:181-208. doi: 10.1016/bs.pbr.2019.10.004. Epub 2019 Nov 29.

Translational validity and implications of pharmacotherapies in preclinical models of Down syndrome

Rueda N, Flórez J, Dierssen M, Martínez-Cué C.

Prog Brain Res. 2020;251:245-268. doi: 10.1016/bs.pbr.2019.10.001. Epub 2019 Nov 1.

A Brief Informant Screening Instrument for Dementia in the ICU: The Diagnostic Accuracy of the AD8 in Critically Ill Adults Suspected of Having Pre-Existing Dementia

Duggan MC, Morrell ME, Chandrasekhar R, Marra A, Frimpong K, Nair DR, Girard TD, Pandharipande PP, Ely EW, Jackson JC.

Dement Geriatr Cogn Disord. 2019;48(5-6):241-249. doi: 10.1159/000490379. Epub 2020 Apr 7.

Delirium superimposed on dementia

Morandi A, Bellelli G.

Eur Geriatr Med. 2020 Feb;11(1):53-62. doi: 10.1007/s41999-019-00261-6. Epub 2019 Nov 14.

Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study

Pérez-Grijalba V, Romero J, Pesini P, Sarasa L, Monleón I, San-José I, Arbizu J, Martínez-Lage P, Munuera J, Ruiz A, Tárraga L, Boada M, Sarasa M.

J Prev Alzheimers Dis. 2019;6(1):34-41. doi: 10.14283/jpad.2018.41.

Exploring the relationship between physical activity, beta-amyloid and tau: A narrative review

Brown BM, Peiffer J, Rainey-Smith SR.

Ageing Res Rev. 2019 Mar;50:9-18. doi: 10.1016/j.arr.2019.01.003. Epub 2019 Jan 4.

Inflammatory markers in Alzheimer's disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies

Shen XN, Niu LD, Wang YJ, Cao XP, Liu Q, Tan L, Zhang C, Yu JT.

J Neurol Neurosurg Psychiatry. 2019 May;90(5):590-598. doi: 10.1136/jnnp-2018-319148. Epub 2019 Jan 10.

Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer's Disease (AD): A Systematic Review and Meta-Analysis

Ng TKS, Ho CSH, Tam WWS, Kua EH, Ho RC.

Int J Mol Sci. 2019 Jan 10;20(2):257. doi: 10.3390/ijms20020257.

Causes and Patterns of Dementia: An Update in the Era of Redefining Alzheimer's Disease

James BD, Bennett DA.

Annu Rev Public Health. 2019 Apr 1;40:65-84. doi: 10.1146/annurev-publhealth-040218-043758. Epub 2019 Jan 14.

Prevalence of abnormal Alzheimer's disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples

Wolfsgruber S, Molinuevo JL, Wagner M, Teunissen CE, Rami L, Coll-Padrós N, Bouwman FH, Slot RER, Wesselman LMP, Peters O, Luther K, Buerger K, Priller J, Laske C, Teipel S, Spottke A, Heneka MT, Düzel E, Drzezga A, Wiltfang J, Sikkes SAM, van der Flier WM, Jessen F; Euro-SCD working group.

Alzheimers Res Ther. 2019 Jan 17;11(1):8. doi: 10.1186/s13195-018-0463-y.

Prediction of Alzheimer's disease with serum lipid levels in Asian individuals: a meta-analysis

Wu Y, Wang Z, Jia X, Zhang H, Zhang H, Li J, Zhang K.

Biomarkers. 2019 Jun;24(4):341-351. doi: 10.1080/1354750X.2019.1571633. Epub 2019 Feb 13.

M/EEG-Based Bio-Markers to Predict the MCI and Alzheimer's Disease: A Review From the ML Perspective

Yang S, Bornot JMS, Wong-Lin K, Prasad G.

IEEE Trans Biomed Eng. 2019 Oct;66(10):2924-2935. doi: 10.1109/TBME.2019.2898871. Epub 2019 Feb 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias